In talc case, reorg ruling goes J&J’s way, keeping bankruptcy in playnews2021-08-27T15:42:30+00:00August 27th, 2021|Fierce Pharma|
In talc case, reorg ruling goes Johnson & Johnson’s way, keeping bankruptcy in playnews2021-08-27T15:42:30+00:00August 27th, 2021|Fierce Pharma|
BioMarin’s dwarfism drug Voxzogo scores European nod for young children, awaits looming FDA decisionnews2021-08-27T15:32:12+00:00August 27th, 2021|Fierce Pharma|
Show me the funny: FDA social media account gets spunky, adding wit and wordplay to combat misinformationnews2021-08-27T15:17:24+00:00August 27th, 2021|Fierce Pharma|
NICE rebuffs J&J’s Darzalex price for newly diagnosed myeloma but leaves negotiation door opennews2021-08-27T14:23:53+00:00August 27th, 2021|Fierce Pharma|
Contaminant in Moderna COVID-19 vaccine vials found in Japan was metallic particles: reportnews2021-08-27T13:47:08+00:00August 27th, 2021|Fierce Pharma|
ESC 2021: Eli Lilly, Boehringer’s Jardiance racks up data for 2nd nod in crowded heart failure fieldnews2021-08-27T13:17:56+00:00August 27th, 2021|Fierce Pharma|
BioNTech selects Rwanda, Senegal for potential malaria and tuberculosis mRNA vaccine manufacturingnews2021-08-27T12:55:15+00:00August 27th, 2021|Fierce Pharma|
Stand Up to Cancer’s annual star-studded fundraiser telecast nods to pharma partner effortsnews2021-08-27T11:55:56+00:00August 27th, 2021|Fierce Pharma|
Fierce Pharma Asia—Samsung’s $205B investment; Moderna COVID vaccine impurities; Brii’s COVID antibody datanews2021-08-27T09:16:34+00:00August 27th, 2021|Fierce Pharma|
